• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MEDTRONIC TRANSCATHETER VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MEDTRONIC TRANSCATHETER VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV Back to Search Results
Model Number MDT-TRANS VALVE
Device Problems Partial Blockage (1065); Degraded (1153); Reflux within Device (1522)
Patient Problems Aortic Valve Stenosis (1717); Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 02/13/2021
Event Type  Injury  
Event Description
Medtronic received information via literature comparing valve-in-valve transcatheter aortic valve replacement (viv tavr) versus re-do surgical aortic valve replacement (savr) for bioprosthetic valve degeneration.All data were collected from a meta-analysis literature review of multiple databases from inception through august 2020.Nine observational studies were analyzed, comprising a combined population of 2,891 patients who were predominantly male with a mean age of 75 years.The viv tavr group involved 1,395 patients and the re-do savr group involved 1,496 patients.Multiple manufacturer¿s devices were implanted in the study population.Among all patients, implants involved several medtronic models, including hancock and mosaic surgical bioprosthetic valves and corevalve and engager transcatheter bioprosthetic valves (unique device identifier numbers not provided).Among all patients, cumulative mortality (mean follow-up of 26 months) was 22% in the viv group and 19.6% in the re-do savr group.No further information was provided on the nature/causes of these deaths in the meta-analysis.Based on the available information medtronic product was not directly associated with the deaths.Among all patients, adverse events included: bioprosthetic valve degeneration, leading to aortic stenosis and/or aortic regurgitation, requiring viv tavr or re-do savr to resolve.Based on the available information medtronic product was directly associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
 
Manufacturer Narrative
Citation: thandra a.; et al.Valve-in-valve transcatheter aortic valve replacement versus redo surgical valve replacement for degenerated bioprosthetic aortic valve: an updated meta-analysis comparing midterm outcomes.Catheter cardiovasc interv.2021 jun 1;97(7):1481-1488.Doi: 10.1002/ccd.29541.Pmid: 33580743.Epub 2021 feb 13 earliest date of publication used for date of event.Medtronic products referenced: hancock (pma# p870078, product code: dye); (pma# p990064, product code: dye); corevalve (pma# p130021, product code: npt); engager (pma# n/a, product code: n/a).(earliest approved product used for product code and pma#) no unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEDTRONIC TRANSCATHETER VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key15090187
MDR Text Key296467183
Report Number2025587-2022-02084
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 07/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/23/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberMDT-TRANS VALVE
Device Catalogue NumberMDT-TRANS VALVE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/27/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-